Lundbeck is Hiring! Check it out! (Isn’t it tempting?)
H. Lundbeck A/S (LUN), Denmark’s second-largest drugmaker, plans to hire more than 200 salespeople in the U.S. to market its new anti-depressant Brintellix ahead of anticipated approval from regulators.
Peak sales of Brintellix, which will be co-promoted with Japanese partner Takeda Pharmaceutical Co., may reach $1 billion to $2 billion, Chief Financial Officer Anders Gotzsche said in a phone interview today. “It will be a significant sales force that Takeda and Lundbeck are providing for the launch of Brintellix,” he said. “It will definitely be more than 200.”
Help employers find you! Check out all the jobs and post your resume.
